Valuation (47%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 230.15 | N/A |
| PEG Ratio (TTM) | -4.96 | N/A |
| P/S Ratio (TTM) | 2.43 | N/A |
| P/B Ratio (TTM) | 1.48 | N/A |
| P/FCF Ratio (TTM) | 15.78 | N/A |
| Price to 5YR AVG Earnings Ratio | 183.41 | N/A |
| Price to 5YR AVG FCF Ratio | 7.53 | N/A |
Profitability (25%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.34% | N/A |
| ROE (TTM) | 0.64% | N/A |
| Net Profit Margin (TTM) | 1.06% | N/A |
| ROIC 5YR AVG | 8.33% | N/A |
Growth (70%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 38.80% | -89.76% | 195.97% |
| Revenue | 0.21% | 24.06% | 14.37% |
| Net Income | 39.67% | -71.98% | 205.79% |
| Cash Flow | 6.17% | 15.11% | 12.35% |
Health (49%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.28 | N/A |
| Quick Ratio (TTM) | 0.28 | N/A |
| D/E Ratio (TTM) | 0.30 | N/A |
| Interest Coverage (TTM) | 1.16 | N/A |
| Piotroski F-Score | 6 | N/A |
| Altman Z-Score | 1.43 | N/A |
| LTL to 5YR AVG FCF | 2.88 | N/A |
| Shares Outstanding Growth 5YR AVG | -0.72% | N/A |